Displaying 1 to 20 of 32 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Adhelex Technologies |
Canada | N/A Active |
||
|
|
AkaRx Inc |
United States | N/A Active |
||
|
Alba Therapeutics Corp |
United States | N/A Active |
||
|
|
Cellzome AG A drug discovery and development company and a leader in the use of chemical proteomics technologies. |
Germany | N/A Active |
||
|
|
Ception Therapeutics Inc Ception Therapeutics, Inc. is an emerging biopharmaceutical company. |
United States | N/A Active |
||
|
|
Cleave Biosciences Inc Drug development company focused on novel targets in cellular protein homeostasis pathways |
United States | 1 Oct 2011 | Series A Active |
|
|
|
CoMentis Inc |
United States | N/A |
||
|
|
Cytomyx Holdings PLC |
United Kingdom | N/A |
||
|
|
DecImmune Therapeutics Inc Developer of antibodies to reduce tissue damage and improve ventricular function associated with myocardial infarction |
United States | N/A |
||
|
|
EPIX Pharmaceuticals Inc |
United States | N/A |
||
|
|
Epizyme Inc Focusing on the discovery and development of innovative drugs targeting epigenetic enzymes, in particular histone methyltransferases (HMTs). |
United States | N/A |
||
|
|
Evolva Holding SA |
Switzerland | N/A |
||
|
|
F2G Ltd |
United Kingdom | N/A |
||
|
|
FASgen Inc |
United States | N/A |
||
|
Fate Therapeutics Inc |
United States | 1 Nov 2009 | Series B Initial investment. Round participant. Active |
|
|
|
Inimex Pharmaceuticals Inc |
Canada | N/A |
||
|
|
Intradigm Corp |
United States | N/A |
||
|
Ironwood Pharmaceuticals Inc Entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. |
United States | N/A |
||
|
|
IRX Therapeutics Inc |
United States | N/A |
||
|
|
Lectus Therapeutics Ltd |
United Kingdom | N/A |